ROG.SW vs. NOVN.SW
Compare and contrast key facts about Roche Holding AG (ROG.SW) and Novartis AG (NOVN.SW).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ROG.SW or NOVN.SW.
Performance
ROG.SW vs. NOVN.SW - Performance Comparison
Returns By Period
In the year-to-date period, ROG.SW achieves a 7.98% return, which is significantly lower than NOVN.SW's 11.52% return. Over the past 10 years, ROG.SW has underperformed NOVN.SW with an annualized return of 1.96%, while NOVN.SW has yielded a comparatively higher 5.92% annualized return.
ROG.SW
7.98%
-7.24%
6.92%
11.12%
-0.26%
1.96%
NOVN.SW
11.52%
-9.67%
-2.30%
12.54%
5.59%
5.92%
Fundamentals
| ROG.SW | NOVN.SW | |
|---|---|---|
| Market Cap | CHF 211.40B | CHF 184.65B |
| EPS | CHF 13.25 | CHF 5.02 |
| PE Ratio | 19.81 | 18.40 |
| PEG Ratio | 1.14 | 3.17 |
| Total Revenue (TTM) | CHF 58.79B | CHF 49.94B |
| Gross Profit (TTM) | CHF 42.64B | CHF 37.42B |
| EBITDA (TTM) | CHF 15.92B | CHF 19.71B |
Key characteristics
| ROG.SW | NOVN.SW | |
|---|---|---|
| Sharpe Ratio | 0.59 | 0.83 |
| Sortino Ratio | 0.93 | 1.22 |
| Omega Ratio | 1.12 | 1.16 |
| Calmar Ratio | 0.27 | 1.23 |
| Martin Ratio | 1.94 | 3.50 |
| Ulcer Index | 5.92% | 3.92% |
| Daily Std Dev | 19.46% | 16.59% |
| Max Drawdown | -58.88% | -42.25% |
| Current Drawdown | -31.64% | -11.18% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between ROG.SW and NOVN.SW is 0.61, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Risk-Adjusted Performance
ROG.SW vs. NOVN.SW - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Roche Holding AG (ROG.SW) and Novartis AG (NOVN.SW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ROG.SW vs. NOVN.SW - Dividend Comparison
ROG.SW's dividend yield for the trailing twelve months is around 3.79%, more than NOVN.SW's 3.62% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ROG.SW Roche Holding AG | 3.79% | 3.89% | 3.20% | 2.40% | 2.91% | 2.77% | 3.41% | 3.33% | 3.48% | 2.89% | 2.89% | 2.95% |
NOVN.SW Novartis AG | 3.62% | 3.77% | 3.91% | 3.94% | 3.72% | 3.27% | 3.98% | 3.98% | 4.35% | 3.58% | 3.17% | 3.86% |
Drawdowns
ROG.SW vs. NOVN.SW - Drawdown Comparison
The maximum ROG.SW drawdown since its inception was -58.88%, which is greater than NOVN.SW's maximum drawdown of -42.25%. Use the drawdown chart below to compare losses from any high point for ROG.SW and NOVN.SW. For additional features, visit the drawdowns tool.
Volatility
ROG.SW vs. NOVN.SW - Volatility Comparison
Roche Holding AG (ROG.SW) and Novartis AG (NOVN.SW) have volatilities of 5.44% and 5.54%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ROG.SW vs. NOVN.SW - Financials Comparison
This section allows you to compare key financial metrics between Roche Holding AG and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities